Harmonization of the postgraduate training of both Cli nical Scientists and Physicians, in Laboratory Medicine (LM) has been a goal for many years, for the European Federation of Clinical Chemistry and Laboratory Med icine (EFLM) and the Union Européenne de Médecins Spécialistes (UEMS), Section of Laboratory Medicine/ Medical Biopathology. This was based on the con cept of free movement of people within the European Union.
Much has been achieved within the respective Euro pean organizations in the development of curricula that will harmonize the postgraduate training at least within the European Union (EU).
Advances in the area of diagnostics and the need for particular expertise in distinct areas have led to the emergence of laboratory scientists and physi cians specialized in hematology (including transfu sion medicine), clinical biochemistry, immunology, and microbiology.
However, the training and specialization is varying and practice is of laboratory medicine is polyvalent in some countries and single specialties in others countries.
Moreover, these advances have led to the involvement of nonmedical scientists in the clinical laboratories.
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However, the training and the roles of Medical Doctors and Clinical Scientists in a Clinical labo ratory, differ from country to country. These dif ferences still remain today throughout Europe and even within the EU.
INTRODUCTION
The profession of clinical chemistry and labo ratory medicine is practiced in all of the North Mediterranean countries. However, it differs among countries in many respects, such as back ground training, fields of interest, legal status and professional organization. Both have as objective to promote mutual rec ognition of laboratory specialists within the European Union (EU). This is closely related to the free movement of people, a major goal of European integration. However, in order this pol icy to be accomplished in the field of Laboratory Medicine needs equivalence of standards and harmonization of the training curriculum among member states, both the central tasks of the European professional organizations.
Harmonization of the profession has been an im portant objective, and has a long history. In 1958 -one year after the treaty of Rome was signedrepresentatives of the professional organizations of medical specialists of the sixmember states of the very new European Economic Community (EEC), met in Brussels and created the European Union of Medical Specialists [Union Européenne des Médecins Spécialistes (UEMS)]. The main objectives of the UEMS are: to promote the highest level of training of the medical special ists, medical practice and health care within the EU and to promote free movement of special ist doctors within the EU. The UEMS represents the medical specialist profession in the member states of the EU, to EU authorities and any other authority dealing with questions concerning the medical profession. Laboratory Medicine as a medical specialty is represented in UEMS.
In 1988 the Federation of European Societies for Clinical Chemistry (FESCC) was founded, joining the different national societies for clinical chem istry and laboratory medicine. The harmoniza tion and recognition of laboratory specialists, particularly of scientific and pharmaceutical background, was the main objective from the start. The EC4 was subsequently founded, with the goal to harmonize the training through the production of a syllabus that will be common ly accepted by all members and establishing a European register for highly trained specialist, whatever their background.
Until the early 90's when European Community started to issue directives to the state members to adopt a system on a uniform basis of gradu ation and of postgraduation/specialization for all medical graduates, the training of medi cal doctors in LM was not only variable but in some countries was missing. To be specialized became, over a few years, a prerequisite for practicing the medical activity in a specific pro fessional field.
However, in most European Hospital Laboratories, are employed not only medical doctors but even pharmacy, biology and chemistry graduates (the so called scientists).
The result was that on the one side we had spe cialized MDs, on the other side nonspecialized, nonMD graduates, creating the potential for seri ous issues. Each country developed its own solu tion. Several countries issued by law the training 
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Since 2008 a separate section of Medical Micro biology was created within the UEMS with its own training program. In 1988 Anatomic Pa thology was the first specialist section that split off from laboratory medicine section of UEMS, and was recognized as separate section with the main objective to harmonize the practice of pathology in Europe.
It is important to understand that it is not only that the two professional organization have dif ferences when they try to define the profession of laboratory medicine.
There are huge differences between EU (and of course nonEU) countries. State regulations also allow or not to nonmedical scientists to prac tice the profession of laboratory medicine.
Many specialties are defined differently from country to country within the European Union. 
The name of the discipline also varies between countries and clearly reflects the differences that exist throughout Europe making particu larly challenging the task to harmonize special ist training within the EU and Europe in general.
WHAT IS THE SITUATION NOW IN NORTH MEDITERRANEAN COUNTRIES?
The countries that comprise the North Mediter ranean region are (from west to east):
• Bosnia and Herzegovina 
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All of the above are European countries, with seven of them being EU member states.
In the following paragraphs we try to describe the situation in all north Mediterranean coun tries. Source of our information was the re plies to a questionnaire we sent to all north Mediterranean countries (see Appendix A Questionnaire on next page) and the published documents we found in the internet and scien tific journals.
Most of the countries responded to our ques tionnaire however we did not got responses from Croatia and Montenegro. And while we were able to retrieve information for Croatia from published documents we were unable to have any information from Montenegro. It is not easy to group the practices from these coun tries since there are huge differences. However, and most interestingly all countries claim that their training is EFLM syllabus compliant.
In Spain there are two specialties which are clos er to what EFLM describes as LM are Bioquímica Clínica (which is the monovalent specialty), and Análisis Clínicos (the polyvalent special ty). Medical Genetics, Transfusion Microbiology Virology, Immunology, Laboratory Haematology, Medical Microbiology, and Haemostasis consti tute separate autonomous monovalent special ties requiring special training. Medical doctors and nonmedical scientists (of pharmacy, biol ogy, biochemistry and chemistry background) are eligible for training in LM and are accepted after examination. Training is state regulated the duration is 4 years for everybody and li censed specialists have equal rights in releas ing final results and in providing clinical consul tancy to clinicians. From the remaining separate specialties only Haematology is strictly a medi cal specialty and genetics is not yet a medical specialty. The training program is compliant to EFLM syllabus.
In France we discovered that while MD's and Pharmacy graduates can work as LM specialists in all labs and the name of the specialty here is Biologie médicale, nonmedical scientists can work only in University Hospital labs and when it comes to who has the rights in releasing final results this is not granted to all clinical scientists and they cannot provide any clinical consultan cy. Training for medical and pharmacy scientists is state regulated is ELFM syllabus compliant and the total duration of studies is 10 years (in cluding the undergraduate studies).
In Italy the name is Laboratory Medicine, the situation is closer to Spain concerning the type of university degrees that are accepted for training. Nonmedical trained specialists share the same rights in respect of releasing the final results but are not allowed to provide clinical consultancy. Only medical genetics represent an autonomous specialty. The training program is state regulated and is (at least in part) EFLM syllabus compliant.
Clinical Chemistry and Laboratory Medicine (CCLM) is a scientific discipline within medicine in Slovenia, is the largest subdiscipline of laborato ry medicine, and is named Medical Biochemistry (Medicinska Biokemija). The practice of Medical Biochemistry in Slovenia includes clinical bio chemistry (including toxicology, therapeutic drug monitoring, endocrinology, molecular diagnos tics, immunology), hematology and coagulation. The training is 4 years for all, it is state regulated and open to medicine, pharmacy, chemistry, bio chemistry, or other relevant university studies degrees and finally is ELFM syllabus compliant. 
Clinical chemistry and Medical biochemistry is the terms that used in Bosnia and Herzegovina to describe the profession. the specialty is open to scientists from Medical schools, Pharmacy and nonmedical (biologists, biochemists, chem ists and other graduates from lifesciences). State regulated training is provided for both
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APPENDIX A -Questionnaire
What is the term that describes best the specialty (Clinical Chemistry and Laboratory
No
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medical and nonmedical background candi dates. However nonmedical scientists are not allowed to do clinical consultancy. Molecular di agnostics, immunology, laboratory hematology medical microbiology and transfusion medicine are separate monovalent medical specialties in this country. Finally, the training program is not EFLM syllabus compliant.
Medical biochemistry and Medical biochemist
(Specijalist Medicinske Biokemije I Laboratorijske Medicine) are terms commonly used in Croatia, equivalent to Clinical Chemistry and Clinical Chemist, respectively, in most European coun tries. Medical biochemistry is almost exclusively practiced by medical biochemists. Medical bio chemistry in Croatia comprises clinical biochem istry, haematology and coagulation, immunol ogy, toxicology and therapeutic drug monitoring and endocrinology. Bloodbanking, microbiology and cytogenetics are separate entities. Medical Biochemistry is studied at the Faculty of Pharmacy and Biochemistry. University degree (Master of Science) is earned after the 5 years of the studies and postgraduate training which is 1 year follows, it is state regulated and is ELFM syllabus compliant. The Faculty of Pharmacy and Biochemistry provides the postgraduate educa tion within the three years of Doctoral studies for: (a) Pharmacy sciences; and (b) Biomedical sciences. PhD degree is requirement for a head of the clinical laboratory at the university hospi tal. However, PhD degree is not a requirement for medical biochemistry specialists to practice the profession in a laboratory.
In Serbia, the terms used are Clinical Biochemistry, Laboratory Medicine, and Medical Biochemistry and only Medical Doctors and Pharmacists are al lowed to enter the profession. The training is 34 years depending on background, it is also state regulated compliant to EFLM syllabus but medi cal genetics transfusion medicine immunology and microbiology are separate medical special ties. And finally all specialists have the right to both release results and provide clinical consul tancy. Kosovo although it is part of Serbia is a recent full member of IFCC. Regulation of the profession in kosovo is similar to that in Serbia only recently only Medical Doctors can enter the profession.
Small but significant differences we can see in FYROM where the term Medical Biochemistry and Clinical Chemistry are used. While Medical Doctors, Pharmacists and nonmedical scientists are allowed to enter the profession only MD's and Pharmacists have the right to release re sults and provide consultancy. Moreover, train ing is state regulated but only for medical and pharmacists it is 4 years and it is EFLM syllabus compliant. No postgraduate training is provided for nonmedical scientists.
In Albania, the name is Clinical Biochemistry is only open to medical doctors and the training is four years it is state regulated and compliant to EFLM and UEMS syllabus. Clinical biochemistry as a specialty here incorporates Haematology and Immunology but Microbiology is a seperate medical specialty.
In Greece and Cyprus, Medical Biopathology (Iatriki Biopathologia) is the state regulated multidisciplinary medical specialty that is given only to Medical Doctors. It is 5 years in dura tion and incorporates microbiology, laboratory haematology, immunology, biochemistry and transfusion medicine. However this training pro gram is partly EFLM syllabus compliant. Medical Genetics is a new state regulated medical spe cialty which is going to be open to both medical and nonmedical scientists, but the training pro cess has not been decided yet. A medical spe cialty under the name Clinical Chemistry (open to both medical and nonmedical scientists) is inactive and no regulatory laws are in practice to govern the training of medical and nonmedical scientists. The Greek society for clinical chemis try and clinical biochemistry understanding the
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gap in nonmedical scientists issued a training program that is compliant to EFLM syllabus and it is available for all nonmedical scientists.
In Turkey, the situation is a bit more complicated. Training is performed either at hospitals or med ical faculties in the universities. Although there is a core curriculum for the training from minis try of health each hospital or medical faculty has its own training program. The graduates from the Medical, Pharmaceutical, Chemistry facul ties can participate at an examination in order to start training, but only the medical graduates can be trained at the Medical faculties. Nonmedical graduates can be trained only at the state hos pitals. They all take exams organised by their or ganisations in order get the diploma. The gradu ates with the Medical Biochemistry Diplomas all can work at the Hospital laboratories by law. But the MoH does not allow them for working at the hospital laboratories belonged to the MoH because the MoH and the medical labora tory associations or societies except the Turkish Biochemistry Society are strongly against to the training of nonmedical graduates for becoming Medical Biochemist.
IS THE PROFESSION OF LABORATORY MEDICINE CHANGING?
The definition of Laboratory medicine is not a static one. Changes in technology and in the economic environment drive the changes in the profession. Techniques that a few years ago were available only for research now are ready for everyday clinical use. Moreover, the need for better and individualised care together with these emerging technologies has driven many laboratory tests outside the safe laboratory en vironment to the clinicians and in certain cases to the patients themselves. Who has the right to perform laboratory tests? This also needs to be redefined in the next years.
Changes due to technology
During the last 1020 years, major scientific and technological advances were the cause of evo lutional changes that happened in the practice of laboratory medicine:
First, the rise of new technologies that produce biomedical "big data" (next generation sequenc ing, multiparameter/multiplex flow cytometry, highthroughput proteomics and metabolomics, systems biology analysis) has caused us to re think the best approach to diagnostics. Whereas formerly one could easily spend one's clinical and investigative career developing expertise in just a few analytes, we now have the opportunity to begin to crack the incredible redundant complex ity of living organisms. Moreover, the implemen tation and growth of clinical testing using mass spectrometry and molecular diagnostics. Once only basic research tools, now these technolo gies provide sameday measurement of proteins, nucleic acids, and therapeutic drugs, improving patient care in complex medical cases.
Second, the advent of the electronic medical re cord (EMR) has added to this potential but, more importantly, has made it much more possible to carry out "costefficient" clinical consultation in laboratory diagnostics on specific patients across a wider geographic area. At least theoret ically, one pathologist can now consult quickly on multiple patients from a remote location.
Third, pointofcare laboratory testing is advanc ing at a furious pace, resulting in both potential great benefits (imagine each clinical doctor with a handheld device) and potential dangers (the clinician might not be able to tell when the in strument is pout of control or not working at all).
Finally, highthroughput automation, combined with electronic identification technologies, pro vides a platform for reduction of laboratory testrelated medical errors.
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All of these changes work toward progressively greater centralisation. The risk of our profession to become "big business" in its underlying structure is evident, and this makes our second objective (the research) even more difficult.
Changes due to increasing economic restrictions
Governments and private health-care providers try to reduce the cost of healthcare in general and laboratory were easy targets. Laboratory consolidations, outsourcing of services, and hostile takeovers of hospital laboratories by commercial companies were common occurrences in the US in the mid-1990s. These measures led to a reduction not only in the number of positions for clinical laboratory staff, but also to the closing of many medical technology schools, and downsizing of postdoctoral training programs. These practices crossed the ocean and are now common practices in many European countries. Consolidation and, in some cases, regionalisation of laboratory services with the creation of individual laboratories serving multiple healthcare facilities is now the driving force in many countries. Healthcare in Europe used to be different than in US but is facing the dangers of an increased privatisation. The private-public competition also contributed to the increased perception of health as a commodity (the product of clinical laboratories was no exception). This is a dangerous path often ignoring the importance and the true impact of diagnostic testing in patient's health.
Changes due to regulatory requirements
Furthermore, the regulatory requirements, quality assessment programs, compliance issues, and general administrative responsibilities of laboratory directors have significantly increased over the past decade. As a result of these clinical service demands, the academic aspects of the profession and the time to participate in research have seemingly suffered.
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